Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

pembrolizumab 553Specimen Handling 466Carboplatin 442Magnetic Resonance Spectroscopy 430Cyclophosphamide 415Cisplatin 397Radiotherapy 312Gemcitabine 309Bevacizumab 309Paclitaxel 295Biopsy 259Drug Therapy 249Capecitabine 242fludarabine 239Oxaliplatin 239Nivolumab 225venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 186Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 147durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × small molecule inhibitor THX-B × Clear all
NCT05694715 2026-03-17

Combination Therapy in Cancers With Mutations in DNA Repair Genes

University of California, San Francisco

Phase 1 Recruiting
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡